0001645182-19-000002.txt : 20190514 0001645182-19-000002.hdr.sgml : 20190514 20190513193912 ACCESSION NUMBER: 0001645182-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190514 DATE AS OF CHANGE: 20190513 EFFECTIVENESS DATE: 20190514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001637715 IRS NUMBER: 472309515 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-339502 FILM NUMBER: 19820111 BUSINESS ADDRESS: STREET 1: P.O. BOX 675614 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 BUSINESS PHONE: 619-733-3852 MAIL ADDRESS: STREET 1: P.O. BOX 675614 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 D 1 primary_doc.xml X0708 D LIVE 0001637715 Reneo Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 858-283-0280 DELAWARE None None Corporation true 2014 Michael Grey 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Director Niall O'Donnell, Ph.D. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Executive Officer Director Lon Cardon, Ph.D. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Director Ed Mathers 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Director Johan Kordel, Ph.D. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Director Art Pappas 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Director Wendy Johnson 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Executive Officer Alejandro Dorenbaum, M.D. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2019-05-01 false true false 0 25000002 25000002 0 The Total Offering Amount and Total Amount Sold reflect the total shares offered and sold in a milestone closing of a previously disclosed equity financing of the Company. false 9 0 0 0 false Reneo Pharmaceuticals, Inc. /s/ Niall O'Donnell, Ph.D. Niall O'Donnell, Ph.D. President and CEO 2019-05-09